Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52,265,866
-
Total 13F shares
-
26,922,182
-
Share change
-
-42,714
-
Total reported value
-
$186,827,845
-
Price per share
-
$6.94
-
Number of holders
-
104
-
Value change
-
+$1,907,355
-
Number of buys
-
48
-
Number of sells
-
44
Institutional Holders of ENZO BIOCHEM INC - Common Stock (ENZB) as of Q4 2016
As of 31 Dec 2016,
ENZO BIOCHEM INC - Common Stock (ENZB) was held by
104 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,922,182 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, Evermore Global Advisors, LLC, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, BlackRock Institutional Trust Company, N.A., VANGUARD GROUP INC, BlackRock Fund Advisors, ACADIAN ASSET MANAGEMENT LLC, First Light Asset Management, LLC, and GILDER GAGNON HOWE & CO LLC.
This page lists
104
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.